Prognostic comparison of COVID-19 outpatients and inpatients treated with Remdesivr: A retrospective cohort study.

Shokoofeh ZamaniMohammad AlizadehEhsan ShahrestanakiSahar Mohammadpoor NamiMostafa QorbaniMaryam AalikhaniSaeed Hassani GelsefidNami Mohammadian Khonsari

Published in: PloS one (2022)

Based on the results of this study, the outcome, signs, and symptoms of inpatient and outpatient Remdesivir treatment groups did not differ significantly. Hence in COVID-19 surges where we have limitations in admitting patients, outpatient Remdesivir treatment for those without any underlying diseases can be a proper management method.

Keyphrases

coronavirus disease
sars cov
newly diagnosed
end stage renal disease
ejection fraction
mental health
prognostic factors
combination therapy
respiratory syndrome coronavirus